Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Azaspiracid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01502
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Marine Algal Toxin |
DME Modulation |
Azaspiracid up-regulates the expression of DME MGST2 |
[1] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME MGST2 |
[2] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME MGST2 |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Dust |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Dust inhibits the expression of DME MGST2 |
[4] |
Particulate matter |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Particulate matter inhibits the expression of DME MGST2 |
[5] |
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution inhibits the expression of DME MGST2 |
[6] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bilirubin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00877
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Bilirubin inhibits the expression of DME MGST2 |
[7] |
Pyrrolizidine alkaloid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Pyrrolizidine alkaloid inhibits the expression of DME MGST2 |
[8] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Apple polyphenol extract |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00757
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Plant Extract |
DME Modulation |
Apple polyphenol extract up-regulates the expression of DME MGST2 |
[9] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME MGST2 |
[10], [11] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME MGST2 |
[12] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME MGST2 |
[13] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME MGST2 |
[14], [15] |
Estradiol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol up-regulates the expression of DME MGST2 |
[16] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME MGST2 |
[17] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME MGST2 |
[5] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Quercetin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Quercetin inhibits the drug-metabolizing activity of DME MGST2 |
[18] |
Trichostatin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01492
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Trichostatin A up-regulates the expression of DME MGST2 and leads to increasing the drug-metabolizing activity of this enzyme |
[19] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME MGST2 |
[20] |
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME MGST2 |
[21] |
|
|
|
|
|
|